Ischemic versus Bleeding Outcomes after Percutaneous Coronary Interventions in Patients with High Bleeding Risk

Patients undergoing percutaneous coronary intervention (PCI) often have high-bleeding-risk (HBR) factors. Dual antiplatelet therapy (DAPT) further increases this risk of bleeding. We sought to compare clinical outcomes according to presence or absence of HBR factors in patients with elevated ischemic risk (DAPT score ≥ 2) undergoing PCI. We evaluated all patients undergoing PCI at MedStar Washington Hospital Center (January 2009 to July 2018) with DAPT score ≥2, which is associated with elevated risk of ischemic events.

Source: The American Journal of Cardiology - March 16, 2020 Category: Cardiology Authors: Deepakraj Gajanana, Toby Rogers, William S. Weintraub, Paul Kolm, Micaela Iantorno, Nauman Khalid, Yuefeng Chen, Evan Shlofmitz, Jaffar M. Khan, Anees Musallam, Itsik Ben-Dor, Lowell F. Satler, Cheng Zhang, Rebecca Torguson, Ron Waksman Source Type: research